Authors:
Tobin, CM
Sunderland, J
White, LO
MacGowan, AP
Citation: Cm. Tobin et al., A simple, isocratic high-performance liquid chromatography assay for linezolid in human serum, J ANTIMICRO, 48(5), 2001, pp. 605-608
Citation: Rj. Fass et J. Barnishan, Comparison of antimicrobial in vitro activities against Streptococcus pneumoniae independent of MIC susceptibility breakpoints using MIC frequency distribution curves, scattergrams and linear regression analyses, J ANTIMICRO, 48(5), 2001, pp. 609-615
Citation: S. Boyle-vavra et al., Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate, J ANTIMICRO, 48(5), 2001, pp. 617-625
Authors:
Mavroidi, A
Tzelepi, E
Tsakris, A
Miriagou, V
Sofianou, D
Tzouvelekis, LS
Citation: A. Mavroidi et al., An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1, J ANTIMICRO, 48(5), 2001, pp. 627-630
Authors:
Kehrenberg, C
Salmon, SA
Watts, JL
Schwarz, S
Citation: C. Kehrenberg et al., Tetracycline resistance genes in isolates of Pasteurella multocida, Mannheimia haemolytica, Mannheimia glucosida and Mannheimia varigena from bovine and swine respiratory disease: intergeneric spread of the tet(H) plasmid pMHT1, J ANTIMICRO, 48(5), 2001, pp. 631-640
Authors:
Goldstein, EJC
Citron, DM
Merriam, CV
Warren, YA
Tyrrell, K
Fernandez, H
Citation: Ejc. Goldstein et al., Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections, J ANTIMICRO, 48(5), 2001, pp. 641-651
Authors:
Skov, R
Christensen, JJ
Korner, B
Frimodt-Moller, N
Espersen, F
Citation: R. Skov et al., In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin, J ANTIMICRO, 48(5), 2001, pp. 653-658
Authors:
Ho, PL
Yung, RWH
Tsang, DNC
Que, TL
Ho, M
Seto, WH
Ng, TK
Yam, WC
Ng, WWS
Citation: Pl. Ho et al., Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000, J ANTIMICRO, 48(5), 2001, pp. 659-665
Citation: Ph. Edelstein et al., BMS-284756 (T-381 1ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L-pneumophila pneumonia and pharmacokinetics in guinea pigs, J ANTIMICRO, 48(5), 2001, pp. 667-675
Authors:
Ioannidis, JPA
Contopoulos-Ioannidis, DG
Chew, P
Lau, J
Citation: Jpa. Ioannidis et al., Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections, J ANTIMICRO, 48(5), 2001, pp. 677-689
Authors:
Contopoulos-Ioannidis, DG
Ioannidis, JPA
Chew, P
Lau, J
Citation: Dg. Contopoulos-ioannidis et al., Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections, J ANTIMICRO, 48(5), 2001, pp. 691-703
Authors:
Banfi, E
Mamolo, MG
Zampieri, D
Vio, L
Bragadin, CM
Citation: E. Banfi et al., Antimycobacterial activity of N-1-{1-[3-aryl-1-(pyridin-2-, 3-or 4-yl)-3-oxo] propyl}-2-pyridinecarboxamidrazones, J ANTIMICRO, 48(5), 2001, pp. 705-707
Authors:
Alovero, F
Barnes, A
Nieto, M
Mazzieri, MR
Manzo, RH
Citation: F. Alovero et al., Comparative study of new benzenesulphonamide fluoroquinolones structurallyrelated to ciprofloxacin against selected ciprofloxacin-susceptible and -resistant Gram-positive cocci, J ANTIMICRO, 48(5), 2001, pp. 709-712
Authors:
Muller, FMC
Kurzai, O
Hacker, J
Frosch, M
Muhlschlegel, F
Citation: Fmc. Muller et al., Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis, J ANTIMICRO, 48(5), 2001, pp. 713-715
Authors:
Miyazaki, S
Fujikawa, T
Kanazawa, K
Yamaguchi, K
Citation: S. Miyazaki et al., In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains, J ANTIMICRO, 48(5), 2001, pp. 723-726
Authors:
Turner, J
Howe, RA
Wootton, M
Bowker, KE
Holt, HA
Salisbury, V
Bennett, PM
Walsh, TR
MacGowan, AP
Citation: J. Turner et al., The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model, J ANTIMICRO, 48(5), 2001, pp. 727-730
Authors:
Glatz, K
Szabo, R
Szabo, G
Boriszova, D
Rozgonyi, F
Citation: K. Glatz et al., Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary, J ANTIMICRO, 48(5), 2001, pp. 731-734
Citation: Mr. Hammerschlag, Efficacy and safety of gemifloxacin in the treatment of community-acquiredpneumonia: a randomized, double-blind comparison with trovafloxacin, J ANTIMICRO, 48(5), 2001, pp. 735-735
Authors:
Fung-Tomc, J
Valera, L
Minassian, B
Bonner, D
Gradelski, E
Citation: J. Fung-tomc et al., Activity of the novel des-fluoro(6) quinolone BMS-284756 against methicillin-susceptible and -resistant staphylococci, J ANTIMICRO, 48(5), 2001, pp. 735-738
Authors:
Lascols, C
Bryskier, A
Soussy, CJ
Tankovic, J
Citation: C. Lascols et al., Effect of pH on the susceptibility of Helicobacter pylori to the ketolide telithromycin (HMR 3647) and clarithromycin, J ANTIMICRO, 48(5), 2001, pp. 738-740
Citation: Ej. Threlfall et al., Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A, J ANTIMICRO, 48(5), 2001, pp. 740-741
Authors:
Deguchi, T
Maeda, SI
Tamaki, M
Yoshida, T
Ishiko, H
Ito, M
Yokoi, S
Takahashi, Y
Ishihara, S
Citation: T. Deguchi et al., Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment, J ANTIMICRO, 48(5), 2001, pp. 742-744